» Articles » PMID: 31584987

The Landscape for HIV Pre-exposure Prophylaxis During Pregnancy and Breastfeeding in Malawi and Zambia: A Qualitative Study

Abstract

High HIV incidence rates have been observed among pregnant and breastfeeding women in sub-Saharan Africa. Oral pre-exposure prophylaxis (PrEP) can effectively reduce HIV acquisition in women during these periods; however, understanding of its acceptability and feasibility in antenatal and postpartum populations remains limited. To address this gap, we conducted in-depth interviews with 90 study participants in Malawi and Zambia: 39 HIV-negative pregnant/breastfeeding women, 14 male partners, 19 healthcare workers, and 18 policymakers. Inductive and deductive approaches were used to identify themes related to PrEP. As a public health intervention, PrEP was not well-known among patients and healthcare workers; however, when it was described to participants, most expressed positive views. Concerns about safety and adherence were raised, highlighting two critical areas for community outreach. The feasibility of introducing PrEP into antenatal services was also a concern, especially if introduced within already strained health systems. Support for PrEP varied among policymakers in Malawi and Zambia, reflecting the ongoing policy discussions in their respective countries. Implementing PrEP during the pregnancy and breastfeeding periods will require addressing barriers at the individual, facility, and policy levels. Multi- level approaches should be considered in the design of new PrEP programs for antenatal and postpartum populations.

Citing Articles

Awareness and willingness to use pre-exposure prophylaxis among the University of Zambia students: A cross-sectional study.

Kampamba M, Nelumbu N, Hikaambo C, Mudenda S, Hangoma J, Kunda M Health Sci Rep. 2024; 7(9):e70060.

PMID: 39257911 PMC: 11386235. DOI: 10.1002/hsr2.70060.


Barriers and facilitators to uptake and use of oral pre-exposure prophylaxis in pregnant and postpartum women: a qualitative meta-synthesis.

Liu Y, Zhang L, Chen H BMC Public Health. 2024; 24(1):1653.

PMID: 38902766 PMC: 11191323. DOI: 10.1186/s12889-024-19168-4.


Integration of HIV pre-exposure prophylaxis (PrEP) services for pregnant and breastfeeding women in eight primary care clinics: results of an implementation science study.

Nelson A, Bheemraj K, Dean S, de Voux A, Hlatshwayo L, Mvududu R Res Sq. 2023; .

PMID: 38045335 PMC: 10690321. DOI: 10.21203/rs.3.rs-3648622/v1.


Uptake of and intention to use oral pre-exposure prophylaxis for HIV among pregnant and post-natal women in Eswatini: a cross-sectional survey.

Khumalo P, Mkhonta S, Kindandi K, Matse S, Dlamini P, Tukei V Front Reprod Health. 2023; 5:1253384.

PMID: 37965589 PMC: 10641516. DOI: 10.3389/frph.2023.1253384.


Implementation determinants and strategies in integration of PrEP into maternal and child health and family planning services: experiences of frontline healthcare workers in Kenya.

Wagner A, Beima-Sofie K, Awuor M, Owade W, Neary J, Dettinger J Front Reprod Health. 2023; 5:1205925.

PMID: 37799494 PMC: 10548203. DOI: 10.3389/frph.2023.1205925.


References
1.
Pintye J, Beima-Sofie K, Kimemia G, Ngure K, Trinidad S, Heffron R . "I Did Not Want to Give Birth to a Child Who has HIV": Experiences Using PrEP During Pregnancy Among HIV-Uninfected Kenyan Women in HIV-Serodiscordant Couples. J Acquir Immune Defic Syndr. 2017; 76(3):259-265. PMC: 5634917. DOI: 10.1097/QAI.0000000000001516. View

2.
Davies N, Heffron R . Global and national guidance for the use of pre-exposure prophylaxis during peri-conception, pregnancy and breastfeeding. Sex Health. 2018; 15(6):501-512. PMC: 6790372. DOI: 10.1071/SH18067. View

3.
Donnell D, Baeten J, Bumpus N, Brantley J, Bangsberg D, Haberer J . HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention. J Acquir Immune Defic Syndr. 2014; 66(3):340-8. PMC: 4059553. DOI: 10.1097/QAI.0000000000000172. View

4.
Keating M, Hamela G, Miller W, Moses A, Hoffman I, Hosseinipour M . High HIV incidence and sexual behavior change among pregnant women in Lilongwe, Malawi: implications for the risk of HIV acquisition. PLoS One. 2012; 7(6):e39109. PMC: 3387180. DOI: 10.1371/journal.pone.0039109. View

5.
Mofenson L, Baggaley R, Mameletzis I . Tenofovir disoproxil fumarate safety for women and their infants during pregnancy and breastfeeding. AIDS. 2016; 31(2):213-232. DOI: 10.1097/QAD.0000000000001313. View